Connect with us

CBD News

Group Of Senators Urge FDA To Implement CBD Regulations To Stop The Bad Actors

Published

on

Group-of-Senators-Urge-FDA-to-Implement-CBD-Regulations-to-Stop-the-Bad-Actors

Senators Seek FDA to Implement CBD Regulations

The Food and Drug Administration (FDA) has yet to issue regulations concerning CBD products. This means that largely, popular CBD products such as gummies, tinctures, edibles, and the like are not provided with any oversight – and this can and does have an impact on consumers.

Even so, politicians are demanding that things change, and that the FDA issue the much-needed safety regulations for CBD products. In a recent press conference, Senator Richard Blumenthal urged the FDA to release CBD regulations and to identify the substance’s status – that is, whether it is a food or a drug. He also requested that testing be conducted to determine the contends of products. Senator Blumenthal’s press conference can be viewed here:

“What we need to do is stop the bad actors, rid the market of unsubstantiated and inaccurate health claims, make sure the good guys have a leveled playing field where truth and accuracy are valued and rewarded by consumers and by the regulatory framework,” he said.

Further adding;

“Hemp growers, manufacturers, food producers and most important, consumers, all deserve a regulatory framework that will set rules for classification, labeling, marketing, quality and other important features so that we stop the Wild West claims and make available products that are truly helpful and beneficial to consumers,” he added. “The treatment of pain, anxiety, inflammation, other kinds of maladies may be aided by CBD and consumers deserve the benefits of those treatments but they also deserve to know the truth about the oils, lotions, gummies and other products that are out there.”

The FDA’s website provides information on FDA regulation in a post titled FDA Regulation of Cannabis-Derived Products, Including Cannabidiol (CBD).

Therein, the FDA recognizes the interest in CBD products, and the opportunities that the substance and its derived compounds may offer. The FDA also indicates therein that it is aware that some companies marketing CBD products or CBD-derived formulas are violating the Federal Food, Drug, and Cosmetics act, and are thus putting consumers at risk. As a result, at least for now, the page provides consumers with several resources that may help consumers make decisions concerning CBD.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or medical advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.